ATE247718T1 - Erkennung einer genetischen prädisposition fur osteoporose - Google Patents

Erkennung einer genetischen prädisposition fur osteoporose

Info

Publication number
ATE247718T1
ATE247718T1 AT97917861T AT97917861T ATE247718T1 AT E247718 T1 ATE247718 T1 AT E247718T1 AT 97917861 T AT97917861 T AT 97917861T AT 97917861 T AT97917861 T AT 97917861T AT E247718 T1 ATE247718 T1 AT E247718T1
Authority
AT
Austria
Prior art keywords
osteoporosis
detection
genetic predisposition
genomic dna
methods
Prior art date
Application number
AT97917861T
Other languages
English (en)
Inventor
Gordon W Duff
Graham Russell
Richard Eastell
Original Assignee
Interleukin Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Interleukin Genetics Inc filed Critical Interleukin Genetics Inc
Application granted granted Critical
Publication of ATE247718T1 publication Critical patent/ATE247718T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT97917861T 1996-04-05 1997-04-03 Erkennung einer genetischen prädisposition fur osteoporose ATE247718T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/628,282 US5698399A (en) 1996-04-05 1996-04-05 Detecting genetic predisposition for osteoporosis
PCT/US1997/005626 WO1997038135A1 (en) 1996-04-05 1997-04-03 Detecting genetic predisposition for osteoporosis

Publications (1)

Publication Number Publication Date
ATE247718T1 true ATE247718T1 (de) 2003-09-15

Family

ID=24518226

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97917861T ATE247718T1 (de) 1996-04-05 1997-04-03 Erkennung einer genetischen prädisposition fur osteoporose

Country Status (13)

Country Link
US (1) US5698399A (de)
EP (1) EP0832298B1 (de)
CN (1) CN100347313C (de)
AT (1) ATE247718T1 (de)
AU (1) AU712461B2 (de)
CA (1) CA2226223C (de)
DE (1) DE69724209T2 (de)
ES (1) ES2208892T3 (de)
IL (1) IL122808A (de)
MX (1) MX9800192A (de)
NZ (1) NZ329530A (de)
WO (1) WO1997038135A1 (de)
ZA (1) ZA972909B (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5998137A (en) * 1996-01-17 1999-12-07 Grainger; David J. Methods of diagnosis by detecting polymorphisms in the TGF-β1 promoter
GB9608133D0 (en) * 1996-04-19 1996-06-26 Gemini International Holdings Diagnostic method and apparatus
US6300077B1 (en) 1996-08-14 2001-10-09 Exact Sciences Corporation Methods for the detection of nucleic acids
US6203993B1 (en) 1996-08-14 2001-03-20 Exact Science Corp. Methods for the detection of nucleic acids
GB9621129D0 (en) 1996-10-10 1996-11-27 Duff Gordon W Detecting genetic predisposition to sight-threatening diabetic retinopathy
US6720141B1 (en) * 1999-11-01 2004-04-13 Interleukin Genetics, Inc. Diagnostics and therapeutics for restenosis
US6210877B1 (en) 1997-03-10 2001-04-03 Interleukin Genetics, Inc. Prediction of coronary artery disease
US6524795B1 (en) * 1997-03-10 2003-02-25 Interleukin Genetics, Inc. Diagnostics for cardiovascular disorders
US7820383B2 (en) 1997-03-10 2010-10-26 Interleukin Genetics, Inc. Method for diagnosing myocardial infarction
GB9706359D0 (en) * 1997-03-27 1997-05-14 Gemini International Holdings Polymorphisms of an il-1 receptor antagonist gene
CA2287571A1 (en) * 1997-04-23 1998-10-29 Abbott Laboratories Reagents and methods useful for detecting diseases of the prostate
US20050282198A1 (en) * 1997-05-29 2005-12-22 Interleukin Genetics, Inc. Diagnostics and therapeutics for diseases associated with an IL-1 inflammatory haplotype
GB9711040D0 (en) * 1997-05-29 1997-07-23 Duff Gordon W Prediction of inflammatory disease
US20050032077A1 (en) * 1998-03-10 2005-02-10 Duff Gordon W. Detecting genetic predisposition to sight-threatening diabetic retinopathy
CA2328955C (en) * 1998-04-21 2008-03-18 Interleukin Genetics, Inc. Fetal testing for prediction of low birth weight
US6733967B1 (en) 1998-04-21 2004-05-11 Interleukin Genetics, Inc. Fetal testing for prediction of low birth weight
WO1999066077A2 (en) * 1998-06-16 1999-12-23 Exact Laboratories, Inc. Methods for the detection of nucleic acids
AUPP547398A0 (en) * 1998-08-26 1998-09-17 Medvet Science Pty. Ltd. Predictive assessment of certain skeletal disorders
CA2343049A1 (en) * 1998-09-15 2000-03-23 Signalgene Inc. Combination of markers at the estrogen- and vitamin d-receptor genes or equivalents thereof to prognose a response to osteoporosis therapy
AU2587500A (en) * 1998-11-30 2000-06-19 Drexel University Methods and kits for identifying individuals at risk of developing osteoporosis
US6762023B1 (en) 1998-11-30 2004-07-13 Drexel University Methods for identifying individuals at risk of developing osteoporosis
IL147182A0 (en) * 1999-06-30 2002-08-14 Interleukin Genetics Inc Diagnostics and therapeutics for diseases associated with an il-1 inflammatory haplorype
ES2261239T3 (es) * 1999-08-30 2006-11-16 Interleukin Genetics, Inc. Diagnostico y terapia para la osteoporosis.
US20090023147A1 (en) * 1999-08-30 2009-01-22 Kenneth Kornman Diagnostics and therapeutics for osteoporosis
AU2001257071A1 (en) * 2000-04-17 2001-10-30 Oregon Health & Science University Ext2 as a predictive marker for osteoporosis
WO2002000933A2 (en) * 2000-06-23 2002-01-03 Interleukin Genetics, Inc. Screening assays for identifying modulators of the inflammatory or immune responses
US20030152947A1 (en) * 2001-06-15 2003-08-14 Crossman David C. Methods for detecting and treating the early onset of aging-related conditions
GB2381526A (en) * 2001-11-03 2003-05-07 Sequenom Inc Detection of predisposition to osteoporosis
US20080311581A1 (en) * 2001-11-19 2008-12-18 David Wyllie Functional polymorphisms of the interleukin-1 locus affecting transcription and susceptibility to inflammatory and infectious diseases
KR101019131B1 (ko) * 2001-11-19 2011-03-07 인터레우킨 제네틱스, 인코포레이티드 염증성 질환 및 감염성 질환에 대한 감수성 및 전사에영향을 미치는 인터루킨-1 좌의 기능적 다형성
US20030148288A1 (en) * 2002-02-01 2003-08-07 Yi-Wei Tang Colorimetric genetic test for clinically significant TNF polymorphism and methods of use thereof
US20030198316A1 (en) * 2002-04-17 2003-10-23 Piet Dewaele Osteoporosis screening method
US20040229228A1 (en) * 2002-07-25 2004-11-18 Northwestern University Il-1 genotype in early kidney allograft rejection
WO2004029618A2 (en) * 2002-09-30 2004-04-08 Novartis Ag Methods to predict cholesterol elevations during immunosuppressant therapy
GB0301715D0 (en) * 2003-01-24 2003-02-26 King S College London Detection of predisposition to osteoporosis
CN1863928A (zh) * 2003-08-08 2006-11-15 英特利金遗传学有限公司 骨质疏松的诊断和治疗
WO2009061506A2 (en) * 2007-11-08 2009-05-14 Interleukin Genetics, Inc. Diagnostics for aging-related dermatologic disorders
CA2723247A1 (en) * 2008-05-02 2009-11-05 Interleukin Genetics, Inc. Detecting genetic predisposition to osteoarthritis associated conditions
US20100098775A1 (en) 2008-05-02 2010-04-22 Interleukin Genetics, Inc. Detecting genetic predisposition to osteoarthritis associated conditions
WO2017123696A1 (en) 2016-01-12 2017-07-20 Interleukin Genetics, Inc. Methods for predicting response to treatment
US10329620B2 (en) 2017-01-12 2019-06-25 Cardioforecast Ltd. Methods and kits for treating cardiovascular disease
EP3536853A1 (de) 2018-03-06 2019-09-11 Lenzing Aktiengesellschaft Lyocellfaser mit verringerter pillenbildung
EP3980561A1 (de) 2019-06-06 2022-04-13 Sitokine Limited Zusammensetzungen und verfahren zur behandlung von lungen-, kolorektal- und brustkrebs
WO2021028469A1 (en) 2019-08-12 2021-02-18 Sitokine Limited Compositions and methods for treating cytokine release syndrome and neurotoxicity
WO2021205013A1 (en) 2020-04-09 2021-10-14 Sitokine Limited Compositions and methods for treating covid-19

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5064851A (en) * 1990-07-24 1991-11-12 Pfizer Inc. 3-(1-substituted-pyrazoyl)-2-oxindole derivatives, compositions and use
CA2141300C (en) * 1992-07-31 2006-03-14 Nigel Alexander Morrison Assessment of vitamin d receptors allelic variation
IT1269989B (it) * 1994-09-21 1997-04-16 Dompe Spa Antagonisti recettoriali di il-1 ad aumentata attivita' inibitoria

Also Published As

Publication number Publication date
ZA972909B (en) 1998-10-26
US5698399A (en) 1997-12-16
NZ329530A (en) 1999-10-28
MX9800192A (es) 1998-11-30
DE69724209T2 (de) 2004-06-17
EP0832298A1 (de) 1998-04-01
AU712461B2 (en) 1999-11-04
EP0832298A4 (de) 1999-09-08
IL122808A (en) 2000-08-31
DE69724209D1 (de) 2003-09-25
WO1997038135A1 (en) 1997-10-16
CA2226223C (en) 2001-11-20
EP0832298B1 (de) 2003-08-20
CN1194668A (zh) 1998-09-30
IL122808A0 (en) 1998-08-16
ES2208892T3 (es) 2004-06-16
CA2226223A1 (en) 1997-10-16
AU2607797A (en) 1997-10-29
CN100347313C (zh) 2007-11-07

Similar Documents

Publication Publication Date Title
DE69724209D1 (de) Erkennung einer genetischen prädisposition fur osteoporose
Wylie et al. Novel imprinted DLK1/GTL2 domain on human chromosome 14 contains motifs that mimic those implicated in IGF2/H19 regulation
Pemberton et al. Nonamplifying alleles at microsatellite loci: a caution for parentage and population studies
AU8132194A (en) Single nucleotide polymorphisms and their use in genetic analysis
ATE336591T1 (de) Nachweisverfahren für kurze sequenzvarianten
GB9704054D0 (en) Assay
ATE224456T1 (de) Detektion einer genetischen prädisposition für diabetische retinopathie mit dem risiko des verlusts der sehkraft
CA2300355A1 (en) Detection of genetic alterations of chromosome 20q that are associated with breast cancer
DE69813302D1 (de) Prostatakrebs-Gen
ATE194391T1 (de) Amplifikationsoligonukleotide und sonden für borrelia, die mit lyme kranheit assoziiert sind
ATE231881T1 (de) Verfahren zur einfachen nukleotid-primer- verlängerung zum nachweis spezifischer allele und dafür geeigneter kit
DE69917636D1 (en) Polymerasesignalversuch
ATE399860T1 (de) Mutation innerhalb des connexin 26 gens und bezug zu prelingualer syndromloser taubheit sowie detektionsverfahren
ES2175095T3 (es) Marcadores de adn respecto al tamaño de una camada de cerdos.
ATE278034T1 (de) Verfahren zur erkennung und/oder analyse, unter verwendung von primertechniken, von einfachen nukleotidpolymorphismen in restriktionsfragmenten speziell aus amplifizierten restriktionsfragmenten generiert durch aflp
ATE359374T1 (de) Verfahren zur diagnose der erblichen hemochromatosis
DE69710469D1 (de) Diagnoseverfahren und vorrichtung zum nachweis der prädisposition zu bestimmten krankheitszuständen, insbesondere osteoporose, auf basis von il-6 genpolymorphismus
ES2308852T3 (es) Secuencias genomicas y completas de cdna de apm1 humano especifico para adipocitos y marcadores bialelicos de los mismos.
WO1999066077A3 (en) Methods for the detection of nucleic acids
Zhao et al. Microsatellite markers from a microdissected swine chromosome 6 genomic library
WO1999002735A3 (en) Diagnostic assays and kits for body mass and cardiovascular disorders
DE69919566D1 (de) Analyse von "amplikons" erhalten durch restriktionsendonukleasen
EP0920305A4 (de) Identifizierung von genen, die in multiplen myelom geändert sind
Ohsumi et al. Loss of Heterozygosity in Chromosome-1, Chromosome-5, Chromosome-7 and Chromosome-13 in Mouse Hepatoma Detected by Systematic Genome-Wide Scanning Using Rlgs Genetic-Map
DE69500393D1 (de) Verfahren zur identifizierung von lymphozyten mit mutator-phänotypen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties